
Cap-dependent endonuclease-IN-1
CAS No. 2365473-17-0
Cap-dependent endonuclease-IN-1( —— )
Catalog No. M35745 CAS No. 2365473-17-0
Cap-dependent endonuclease-IN-1 is a highly potent, orally active cap-dependent endonuclease inhibitor with antiviral activity for studying influenza virus infection.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 967 | Get Quote |
![]() ![]() |
5MG | 1292 | Get Quote |
![]() ![]() |
25MG | 2052 | Get Quote |
![]() ![]() |
50MG | 2558 | Get Quote |
![]() ![]() |
100MG | 3168 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameCap-dependent endonuclease-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionCap-dependent endonuclease-IN-1 is a highly potent, orally active cap-dependent endonuclease inhibitor with antiviral activity for studying influenza virus infection.
-
DescriptionCap-dependent endonuclease-IN-1 is an orally active cap-dependent endonuclease inhibitor with high potency. Cap-dependent endonuclease-IN-1 can be used for the research of influenza.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2365473-17-0
-
Formula Weight540.54
-
Molecular FormulaC27H22F2N2O6S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1C2(CN(N3C1=C(OCOC(OC)=O)C(=O)C=C3)[C@H]4C=5C(CSC=6C4=CC=CC6)=C(F)C(F)=CC5)CC2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Ming-Chu Hsu, et al. Cap-dependent endonuclease inhibitors. Patent WO2019144089A1.
molnova catalog



related products
-
2-Methoxy-5-sulfamoy...
Used as intermediates in organic synthesis sulpiride.
-
CINPA1
CINPA1 is a selective inhibitor of constitutive androstane receptor (CAR) with an IC50 of 70 nM for CAR-mediated transcription. CINPA1 can be used in studies about CAR function.
-
ST 271
ST271 is an effective protein tyrosine kinase (PTK) inhibitor.